Articles with "anthracycline chemotherapy" as a keyword



Photo by nci from unsplash

Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.

Sign Up to like & get
recommendations!
Published in 2018 at "Hematology/oncology and stem cell therapy"

DOI: 10.1016/j.hemonc.2017.07.006

Abstract: OBJECTIVE To evaluate the effectiveness and tolerability of neoadjuvant chemotherapy with weekly paclitaxel in combination with weekly carboplatin area under curve 2 followed by anthracycline chemotherapy. PATIENTS AND METHODS This is a retrospective review of… read more here.

Keywords: chemotherapy; negative breast; breast cancer; anthracycline chemotherapy ... See more keywords
Photo from wikipedia

Impact of hypertension on left ventricular function in patients after anthracycline chemotherapy for malignant lymphoma.

Sign Up to like & get
recommendations!
Published in 2020 at "International journal of cardiology"

DOI: 10.1016/j.ijcard.2020.08.019

Abstract: BACKGROUND Hypertension is considered an important risk factors for cancer therapeutics-related cardiac dysfunction (CTRCD) as well as heart failure. However, the impact of hypertension and left ventricular (LV) hypertrophy (LVH), which is associated with hypertension,… read more here.

Keywords: malignant lymphoma; hypertension left; impact hypertension; hypertension ... See more keywords
Photo from wikipedia

Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity

Sign Up to like & get
recommendations!
Published in 2020 at "Cell Death and Differentiation"

DOI: 10.1038/s41418-020-00607-9

Abstract: Anthracyclines are a class of conventional and commonly used frontline chemotherapy drugs to treat breast cancer. However, the anthracycline-based regimens can only reduce breast cancer mortality by 20–30%. Furthermore, there is no appropriate biomarker for… read more here.

Keywords: chemotherapy; anthracycline chemotherapy; breast cancer;
Photo from wikipedia

Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy

Sign Up to like & get
recommendations!
Published in 2020 at "Scientific Reports"

DOI: 10.1038/s41598-020-61927-x

Abstract: Anthracycline chemotherapy is commonly used to treat breast cancer yet may increase the level of matrix metalloproteinases (MMP) -2 and -9, which increase the risk of atherosclerosis. While exercise has been shown to reduce the… read more here.

Keywords: chemotherapy; group; mmp; breast cancer ... See more keywords
Photo from wikipedia

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Science Translational Medicine"

DOI: 10.1126/scitranslmed.adf1147

Abstract: Beta-adrenergic blockade has been associated with improved cancer survival in patients with triple-negative breast cancer (TNBC), but the mechanisms of these effects remain unclear. In clinical epidemiological analyses, we identified a relationship between beta-blocker use… read more here.

Keywords: anthracycline chemotherapy; beta blockade; breast cancer; beta ... See more keywords

Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study

Sign Up to like & get
recommendations!
Published in 2018 at "BMJ Open"

DOI: 10.1136/bmjopen-2018-022622

Abstract: Introduction Cardiovascular disease (CVD) mortality is higher among breast cancer survivors (BCS) who receive chemotherapy compared with those not receiving chemotherapy. Anthracycline chemotherapy is of particular concern due to anthracycline-related impairment of vascular endothelial cells… read more here.

Keywords: chemotherapy; hiit; study; cancer ... See more keywords
Photo from wikipedia

Anthracycline chemotherapy, vascular dysfunction and cognitive impairment: burgeoning topics and future directions.

Sign Up to like & get
recommendations!
Published in 2022 at "Future cardiology"

DOI: 10.2217/fca-2022-0086

Abstract: Anthracyclines, chemotherapeutic agents used to treat common forms of cancer, increase cardiovascular (CV) complications, thereby necessitating research regarding interventions to improve the health of cancer survivors. Vascular dysfunction, which is induced by anthracycline chemotherapy, is… read more here.

Keywords: vascular dysfunction; future directions; cognitive impairment; dysfunction ... See more keywords
Photo from wikipedia

Anthracycline Chemotherapy in Treatuing Advanced Breast Cancer and its effect on Estradiol and Tumor Size

Sign Up to like & get
recommendations!
Published in 2020 at "Indian Journal of Pharmaceutical Sciences"

DOI: 10.36468/pharmaceutical-sciences.spl.23

Abstract: To investigate the therapeutic effect of anthracycline chemotherapy in advanced breast cancer and its influence on estradiol and tumor size, 136 breast cancer patients in Shan Xi Bethune Hospital were divided into anthracycline chemotherapy group… read more here.

Keywords: chemotherapy; anthracycline chemotherapy; chemotherapy group; tumor ... See more keywords